Drug · DIN 00476552
NARDIL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 4, 2022; first marketed December 31, 1981.
- Drug Identification Number (DIN)
- 00476552
- Company (DIN owner)
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Phenelzine N06AF03
- Class
- Human
- Record last updated
- December 31, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PHENELZINE (PHENELZINE SULFATE) | 15 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 4, 2022: NOC 29138New Drug Submission (NDS) · Administrative: Change in Product Ownership
- July 12, 2005: NOC 7238New Drug Submission (NDS) · Manufacturer name change
- January 24, 2001: NOC 2536New Drug Submission (NDS) · Manufacturer name change
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “nardil”. A notice may cover another product or only some lots: read it to see what it covers.
- NARDIL (phenelzine sulfate) ShortageJune 24, 2020 · Drugs · Product safety